Plain-English translation of NCT05680480 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lupus Nephritis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called telitacicept to see if it can help people whose lupus has caused kidney inflammation. You would receive either the new medication at one of two doses, or a placebo (a dummy injection with no active drug), while continuing your regular lupus treatments. Researchers want to learn whether this medication is safe and whether it helps your kidneys heal.
Lupus nephritis is a serious complication that can damage kidneys and affect how well they work. Current standard treatments help some patients, but many still struggle with ongoing kidney inflammation. This trial aims to find out if this medication could offer additional benefit to people receiving standard care.
You likely qualify if…
You likely don't qualify if…
If you join, you'll receive a weekly injection of either the medication or a placebo for 48 weeks while continuing your standard lupus treatments. You'll visit the research clinic regularly so doctors can check how you're doing, run blood tests, and monitor your kidney function. You won't know whether you're getting the actual medication or a placebo — that's why it's called a 'blind' study — which helps researchers see the true effects of the treatment.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China